BRAF inhibitors work by binding to the mutated form of the BRAF protein, thereby blocking its ability to send signals that promote cancer cell growth. This leads to cell death or slowed growth of the cancer cells. Commonly used BRAF inhibitors include vemurafenib and dabrafenib.
